Home
News
About
Company profile
Company culture
Company honor
Orgaization
Branch
Company history
Company staff
Products
Gynecology
Respiratory system
Hormones
Antipyretic analgesic
Spiritual
Antiviral
Antibacterial
Oral anesthetics
Urology
Masks
Water-electrolyte balance
Digestive system
Cardiovascular
Pieces
Nutrition and Metabolism
API
Service
Service concept
Bid Information
Contact
用药常识
女性健康
感冒预防
高血压防治
疼痛防治
家庭保健
儿童健康
心脑血管
Anhui Yukang New Materials Co., Ltd.
Anhui Yukang New Materials Co., Ltd. was established on June 15, 2007 with a registered capital of 30 million yuan. It is a holding subsidiary of Anhui Fengyuan Pharmaceutical Co., Ltd., Anhui Donggeng Chemical Technology Co., Ltd., and Anhui Xuelang Biotechnology Co., Ltd. Shares.
2021
06-16
Anhui Taifu Pharmaceutical Co., Ltd.
Anhui Taifu Pharmaceutical Co., Ltd. (hereinafter referred to as "Taifu Medicine") was changed from Anhui Fengyuan Pharmaceutical Trading Co., Ltd. in September 2010. The registered capital is 10 million, and the registered address is Guzhen, Guzhen County, Bengbu City, Anhui Province. No. 5, Jingyi Road, Development Zone, is a high-tech enterprise, one of the top 100 enterprises in China's pharmaceutical industry, and the first listed company in the pharmaceutical industry in Anhui Province - Anhui Fengyuan Pharmaceutical Co., Ltd. (stock code: 000153, hereinafter referred to as "Fengyuan Pharmaceutical" ”) wholly-owned commercial company
Anhui Fengyuan Weikang API Co., Ltd.
Anhui Fengyuan Weikang API Co., Ltd. is a wholly-owned subsidiary of Anhui Fengyuan Likang Pharmaceutical Co., Ltd. The company is located in the east of Jinger Road and the north of Weisi Road in the Economic Development Zone of Guzhen County. The total investment of the project is 288 million Yuan, covers an area of 26,808.8 square meters, and green area of 16,456 square meters. The company has a young and professional R&D, production, quality control and management team.
Anhui Fengyuan Tushan Pharmaceutical Co., Ltd.
Bengbu Fengyuan Tushan Pharmaceutical Co., Ltd. is a core backbone enterprise affiliated to Anhui Fengyuan Pharmaceutical Co., Ltd. (stock code 000153). It is located in Bengbu, an important business town in northern Anhui and known as the Pearl of the Huaihe River. It is located in Bengbu City, Anhui Province. The beautiful Tianhe coast and the sun of Tushan. The factory is surrounded by mountains and rivers, with a beautiful environment. The 206 National Highway and Beijing-Taiwan Expressway intersect here, and the traffic is convenient. It is an ideal place for pharmaceutical companies.
Fengyuan Pharmaceutical's 2021-2023 Logistics Bidding Announcement
06-09
Likang Pharmaceutical obtained the "High-tech Enterprise Certificate"
05-26
Anhui Province Traditional Chinese Medicine Regulations officially implemented on June 1
Since June 1, the "Regulations on Traditional Chinese Medicine in Anhui Province" has been officially implemented. The "Regulations" were voted and passed at the 17th meeting of the Standing Committee of the 13th Anhui Provincial People's Congress on March 27.
06-03
Qinghai begins to purchase in large quantities, injections gradually become the leading role in centralized procurement
医药网6月1日讯 近日，青海省医保局发布《关于报送2020年省级组织集中Recently, the Qinghai Provincial Medical Insurance Bureau issued the "Notice on Submitting Data Related to the Centralized Procurement of Drugs by Provincial Organizations in 2020", and announced the list of drugs to be procured in Qinghai Province in 2020. Protein, Xuesaitong, Shenkang, butylphthalide and other 49 varieties are listed - so far, another provincial procurement catalogue with volume has surfaced, which has aroused the attention of the industry.带量采购药品相关数据的通知》，公布了青海省2020年带量采购的药品目录，人血白蛋白、血塞通、肾康、丁苯酞等49个品种在列——至此，又一省级带量采购目录浮出水面，引发行业关注。
06-01
Tianjin launches pilot work of unique identification system for medical devices
Pharmaceutical Net, May 28th, Tianjin Drug Administration, Tianjin Medical Security Bureau and Tianjin Municipal Health Commission jointly issued the "Tianjin Municipal Medical Device Unique Identification System Pilot Work Plan", aiming to promote the unique medical device identification system in Tianjin according to law.
05-28
Government Work Report: Increase investment in vaccine and drug research and development, and promote the revitalization and development of traditional Chinese medicine!
Pharmaceutical Net, May 25th, at 9:00 a.m. on May 22nd, the third session of the 13th National People's Congress opened.
05-25
86-0551-64846100
127841476@qq.com
CopyRight © 2022 Anhui BBCA Pharmaceuticals Co., Ltd Powered by：www.300.cn SEO
448022937@qq.com
+182619958320
+0551-64846105